Immunotherapy for aeroallergens
Aeroallergen immunotherapy offers long-term relief for children with hay fever, dust mite allergy, or allergic asthma triggered by airborne allergens. This evidence-based treatment helps retrain the immune system to tolerate these allergens more effectively and greatly improves a patient's quality of life.
What is immunotherapy for aeroallergens and how does it work?
Aeroallergen immunotherapy involves introducing your child’s immune system to small, gradually increasing doses of airborne allergens such as pollen, mould spores, or house dust mites. These allergens are common triggers of allergic rhinitis, asthma, and conjunctivitis, particularly during specific seasons or in indoor environments. By exposing the body to these allergens in a controlled way, the immune system can begin to tolerate them rather than react defensively.
​
The treatment is delivered via two main methods: sublingual immunotherapy (under-the-tongue tablets or drops) and subcutaneous injections. The choice of method depends on the type of allergen, your child’s age, and their individual medical needs. Sublingual immunotherapy is often more convenient for children as it can be administered at home following initial dose monitoring in the clinic. Injectable immunotherapy can be considered and involves a week of injections for 4-6 weeks per year for three years.
​
Throughout the course of treatment, your child will have regular reviews with our allergy team. These visits ensure that the therapy remains safe and effective, and allows us to address any side effects or symptoms. Our goal is not just symptom control but long-term modification of the allergic disease.
What results to expect
Most families notice a significant reduction in allergy symptoms within the first year of treatment, with benefits continuing to improve over time. Children may experience fewer flare-ups, reduced reliance on antihistamines or inhalers, and a better quality of life during high-allergen seasons.
​
After completing the full course of allergy immunotherapy, many children remain symptom-free or experience lasting relief. Early intervention can also reduce the risk of developing new allergies or asthma later in life.